Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

Oregon Health & Science University

United States · North America · Platinum

#98World rank of 1,038
75.2ICI scoreout of 100
#37National rank, of 203 in United States
#38Regional rank, of 231 in North America
1,973Verified industry works, 2021 to 2025
583Company groups worked with (244 on two or more works)

Oregon Health & Science University is ranked #98 of 1,038, with Platinum standing. Its strongest pillar is co-creation (97): 1,973 verified industry works against about 1,019 expected for its mix of fields. It is held back most by breadth (6): partners concentrated in a few research fields.

Research Collaboration Index 2026: #287 of 1,195, Gold standing · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
97

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 1,973 verified works against about 1,019 expected for its fields (1.94 times the expected rate).

Durability20% of the score
94

How much of its industry work sits in sustained partnerships with the same company group. 84 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score
87

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 244 company groups on two or more joint works; 84 sustained partnerships.

Breadth20% of the score
6

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (75.2) is the weighted average of the four percentiles. Rank 98 of 1,038 overall; 37 of 203 in United States; 38 of 231 in North America. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

9.0%of its 21,848 research works in 2021 to 2025 were co-authored with a verified company
1.94Industry co-authorship rate: 1.94 times what its mix of research fields would predict (1,973 verified works; about 1,019 expected)
84sustained partnerships: the same company group on five or more joint works in three or more of the five years

In United States

37 of 203 ranked universities in United States

  1. #35 Emory University world #86, score 76.2
  2. #36 The University of Texas at Austin world #88, score 75.9
  3. #37 Oregon Health & Science University world #98, score 75.2
  4. #38 Texas A&M University world #101, score 75.0
  5. #39 Princeton University world #102, score 74.9

All ranked universities →   North America: 38 of 231 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Strongest sector positions

#30 of 638Pharmaceuticals and Therapeutics633.5 verified works in the sector
#48 of 220Biotechnology and Advanced Therapies76.5 verified works in the sector
#109 of 323Medical Technology and Digital Health62 verified works in the sector
Pharmaceuticals and Therapeutics
633.5#30 of 638
Biotechnology and Advanced Therapies
76.5#48 of 220
Medical Technology and Digital Health
62#109 of 323
Artificial Intelligence
8under 20 works
Software, Cloud and Data
3under 20 works
Climate, Environment and Sustainability
1under 20 works
Quantum Technologies
1under 20 works
Semiconductors and Microelectronics
1under 20 works
Not in any of the 21 sectors
1,187counted in the overall index

786 of its 1,973 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

Oregon Health & Science University co-authored verified work with 583 company groups, consortium papers aside: 244 of them on two or more works, and 84 as sustained partners.

The largest 12 of its 583 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
Johnson & JohnsonUnited StatesMedicine1025 of 5
NovartisSwitzerlandMedicine101.55 of 5
Eli LillyUnited StatesMedicine915 of 5
PfizerUnited StatesMedicine87.55 of 5
AbbVieUnited StatesMedicine86.55 of 5
RegeneronUnited StatesMedicine855 of 5
SanofiFranceMedicine785 of 5
IncyteUnited StatesMedicine535 of 5
Bristol-Myers SquibbUnited StatesMedicine42.55 of 5
Leo PharmaDenmarkMedicine425 of 5
UCB PharmaBelgiumMedicine39.55 of 5
TakedaJapanChemistry365 of 5

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Over time

Verified industry works by year

3972021
434.52022
356.52023
3992024
3862025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Clinical trials (reported, not scored)

39 industry-partnered clinical trials

Trials starting 2021 to 2025 in ClinicalTrials.gov in which a company and this university are the sponsor and a collaborator. Names are matched exactly, so a trial registered only under an affiliated hospital's own name is not counted here, and the count can be well below the university's real trial activity. Trials do not enter the score.

Examples:

  • NCT06953505 At Home Ammonia Monitoring of Inborn Errors of Ammonia Metabolism with Sequitur Health Corp., 2025
  • NCT05185518 Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes with Pacific Diabetes Technologies, 2025
  • NCT06630325 A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer with Eli Lilly and Company, 2025
  • NCT06357676 Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial with Genentech, Inc., 2025
  • NCT06528210 Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer with Merck Sharp & Dohme LLC, 2025
  • NCT06563323 Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) with Janssen Scientific Affairs, LLC, 2025

Evidence checked

2,997 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 1,372 of 4,369 candidate links were set aside.

Why links were set aside
  • 594 company name not written in the author's affiliation
  • 332 ordinary-word name without a company suffix
  • 176 part of a university or public institute's own unit
  • 76 a place or common word that failed its stricter rule
  • 28 excluded after hand audit: Matched from social media handles in affiliation text
  • 25 excluded after hand audit: Matched from Hartford HealthCare (a hospital system) and the city of Hartford
  • 141 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

For your communications

Badges you can use

Platinum standing badge

Use the badge with a link to this page.

GRP Partnership Intelligence Platform

Where Oregon Health & Science University's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, Oregon Health & Science University ranks #287 of 1,195, with Gold standing. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.